Lakefront Biotherapeutics (GLPGF) Current Taxes (2013 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Current Taxes for 14 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Current Taxes rose 420.54% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 420.54% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 300.78% from the prior year.
• Current Taxes was $1.1 million for Q1 2026 at Lakefront Biotherapeutics, down from $1.1 million in the prior quarter.
• Over five years, Current Taxes peaked at $3.0 million in Q1 2022 and troughed at $60252.6 in Q4 2023.
• A 5-year average of $841687.0 and a median of $408000.2 in 2025 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes plunged 94.67% in 2024 and surged 420.54% in 2026, its largest moves.
• Over 5 years, Current Taxes stood at $1.0 million in 2022, then slumped by 94.22% to $60252.6 in 2023, then soared by 341.61% to $266080.3 in 2024, then surged by 318.23% to $1.1 million in 2025, then retreated by 4.05% to $1.1 million in 2026.
• The last three Current Taxes figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $408000.2 (Q3 2025), per Business Quant data.